Horizon 2020 Health

SC1-BHC-07-2019: Regenerative medicine: from new insights to new applications

Deadline: 16 april 2019

Regenerative medicine offers hope for untreatable disease and the ageing population, improved quality of life and reduced medical costs. However, so far, regenerative medicine has not yet proved itself in the clinic beyond rare diseases or conditions of limited public health importance. With recent scientific discoveries opening up new approaches to regenerative medicine, the challenge is to use these to extend the regenerative approach to major diseases and conditions.

Projects should focus on innovative translational research to develop regenerative processes towards the ultimate clinical goal of addressing unmet clinical needs of large patient groups. 

Financiert projecten binnen:

De officiële aanmelding van Horizon 2020 Health

Contact betreffende subsidie van Horizon 2020 Health

Past deze aanmelding bij uw project? We nemen graag contact met u op voor een vrijblijvend advies over de Horizon 2020 Health subsidiemogelijkheden voor uw project.

Over Horizon 2020 Health

With support from Horizon 2020 Health you will be able to conduct international research projects in support of EU policies for health. Support will be given to projects aimed at: Health promotion and prevention; diagnosis improvement; innovative treatments and technologies; active and healthy aging; citizen-centered care; and improving health information etc.

Meer over de subsidies